INO Historical PE Ratio image   This INO PE ratio history page last updated 11/10/2022
INO Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/8/2022
2.14-0.15-0.60NA
Q2 2022
8/9/2022
2.10-0.46-1.84NA
Q1 2022
5/10/2022
2.49-0.36-1.44NA
Q4 2021
3/1/2022
3.24-0.50-2.00NA
Q3 2021
11/9/2021
7.05-0.29-1.16NA
Q2 2021
8/9/2021
9.60-0.39-1.56NA
Q1 2021
5/10/2021
6.67-0.27-1.08NA
Q4 2020
3/1/2021
11.60-0.14-0.56NA
Q3 2020
11/9/2020
8.50-0.26-1.04NA
Q2 2020
8/10/2020
18.99-0.20-0.80NA
Q1 2020
5/11/2020
11.90-0.26-1.04NA
Q4 2019
3/12/2020
9.50-0.38-1.52NA
Q3 2019
11/12/2019
2.44-0.25-1.00NA
Q2 2019
8/8/2019
2.54-0.30-1.20NA
Q1 2019
5/9/2019
3.87-0.30-1.20NA
Q4 2018
3/12/2019
3.56-0.34-1.36NA
Q3 2018
11/8/2018
5.19-0.27-1.08NA
Q2 2018
8/7/2018
4.02-0.08-0.32NA
Q1 2018
5/9/2018
4.83-0.36-1.44NA
Q4 2017
3/14/2018
4.47-0.25-1.00NA
Q3 2017
11/8/2017
5.33-0.40-1.60NA
Q2 2017
8/8/2017
5.43-0.13-0.52NA
Q1 2017
5/10/2017
6.39-0.31-1.24NA
Q4 2016
3/15/2017
6.87-0.35-1.40NA
Q3 2016
11/9/2016
7.43-0.28-1.12NA
Q2 2016
8/8/2016
9.35-0.26-1.04NA
Q1 2016
5/9/2016
9.52-0.11-0.44NA
Q4 2015
3/14/2016
6.68-0.25-1.00NA
Q3 2015
11/9/2015
7.020.070.2825.1
Q2 2015
8/10/2015
8.19-0.11-0.44NA
Q1 2015
5/11/2015
8.01-0.18-0.72NA
Q4 2014
3/16/2015
8.42-0.12-0.48NA
Q3 2014
11/10/2014
11.24-0.12-0.48NA
Q2 2014
8/11/2014
8.97-0.17-0.68NA
Q1 2014
5/12/2014
8.68-0.05-0.20NA
Q4 2013
3/17/2014
13.68-0.07-0.28NA
Q3 2013
11/12/2013
7.00-0.16-0.64NA
Q2 2013
8/9/2013
7.68-0.06-0.24NA
Q1 2013
5/10/2013
2.48-0.06-0.24NA
Q4 2012
3/18/2013
2.120.000.00NA
Q3 2012
11/7/2012
2.68-0.05-0.20NA
INO PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/8/2022
2.14-0.15-1.47NA
Q2 2022
8/9/2022
2.10-0.46-1.61NA
Q1 2022
5/10/2022
2.49-0.36-1.54NA
Q4 2021
3/1/2022
3.24-0.50-1.45NA
Q3 2021
11/9/2021
7.05-0.29-1.09NA
Q2 2021
8/9/2021
9.60-0.39-1.06NA
Q1 2021
5/10/2021
6.67-0.27-0.87NA
Q4 2020
3/1/2021
11.60-0.14-0.86NA
Q3 2020
11/9/2020
8.50-0.26-1.10NA
Q2 2020
8/10/2020
18.99-0.20-1.09NA
Q1 2020
5/11/2020
11.90-0.26-1.19NA
Q4 2019
3/12/2020
9.50-0.38-1.23NA
Q3 2019
11/12/2019
2.44-0.25-1.19NA
Q2 2019
8/8/2019
2.54-0.30-1.21NA
Q1 2019
5/9/2019
3.87-0.30-0.99NA
Q4 2018
3/12/2019
3.56-0.34-1.05NA
Q3 2018
11/8/2018
5.19-0.27-0.96NA
Q2 2018
8/7/2018
4.02-0.08-1.09NA
Q1 2018
5/9/2018
4.83-0.36-1.14NA
Q4 2017
3/14/2018
4.47-0.25-1.09NA
Q3 2017
11/8/2017
5.33-0.40-1.19NA
Q2 2017
8/8/2017
5.43-0.13-1.07NA
Q1 2017
5/10/2017
6.39-0.31-1.20NA
Q4 2016
3/15/2017
6.87-0.35-1.00NA
Q3 2016
11/9/2016
7.43-0.28-0.90NA
Q2 2016
8/8/2016
9.35-0.26-0.55NA
Q1 2016
5/9/2016
9.52-0.11-0.40NA
Q4 2015
3/14/2016
6.68-0.25-0.47NA
Q3 2015
11/9/2015
7.020.07-0.34NA
Q2 2015
8/10/2015
8.19-0.11-0.53NA
Q1 2015
5/11/2015
8.01-0.18-0.59NA
Q4 2014
3/16/2015
8.42-0.12-0.46NA
Q3 2014
11/10/2014
11.24-0.12-0.41NA
Q2 2014
8/11/2014
8.97-0.17-0.45NA
Q1 2014
5/12/2014
8.68-0.05-0.34NA
Q4 2013
3/17/2014
13.68-0.07-0.35NA
Q3 2013
11/12/2013
7.00-0.16-0.28NA
Q2 2013
8/9/2013
7.68-0.06-0.17NA
Q1 2013
5/10/2013
2.48-0.06NANA
Q4 2012
3/18/2013
2.120.00NANA
Q3 2012
11/7/2012
2.68-0.05NANA
Quotes delayed 20 minutes

Email EnvelopeFree INO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Inovio Pharmaceuticals (INO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

INSM PE Ratio History
INSP PE Ratio History
INVA PE Ratio History
INVO PE Ratio History
INZY PE Ratio History
IONS PE Ratio History
IOVA PE Ratio History
IPSC PE Ratio History
IQV PE Ratio History
IRIX PE Ratio History
How should the INO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Inovio Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this INO Historical PE Ratio page.

What is the average historical PE for INO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The INO historical PE ratio using the annualized quarterly earnings method works out to 25.1.

What is the average historical PE for INO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The INO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the INO Historical PE Ratio information for Inovio Pharmaceuticals' stock. The average INO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 25.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average INO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this INO historical PE result, against the recent PE: when this page was posted on 11/9/2022, the most recent closing price for INO had been 2.18, and the most recent quarterly earnings result, annualized, was 0.28. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent INO PE on 11/9/2022 based on annualized quarterly EPS was 7.8. Based on INO's history, that recent PE is low relative to the historical average, with the recent PE 68.9% lower than the historical average PE across our data set for Inovio Pharmaceuticals.

For self directed investors doing their due diligence on INO or any other given stock, valuation analysis for INO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Inovio Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for INO. Thanks for visiting, and the next time you need to research INO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of EMHC, Metals Channel, VNT shares outstanding history.

 

INO Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.